Comparative Pharmacology
Head-to-head clinical analysis: CLOBAZAM versus LOREEV XR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLOBAZAM versus LOREEV XR.
CLOBAZAM vs LOREEV XR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Clobazam is a benzodiazepine that enhances the effect of GABA at the GABA-A receptor, increasing chloride ion conductance and neuronal hyperpolarization. It has a high affinity for the α2 subunit, which may contribute to its anticonvulsant effects.
Levetiracetam is a racetam anticonvulsant that binds to synaptic vesicle glycoprotein 2A (SV2A), reducing neurotransmitter release and neuronal excitability. It also inhibits N-type calcium channels and modulates GABAergic and glutamatergic transmission.
10-60 mg orally once daily, divided into two doses. Typical starting dose: 10 mg twice daily.
50 mg orally once daily, preferably in the evening. Maximum dose 100 mg/day.
None Documented
None Documented
Clinical Note
moderateClobazam + Estrone sulfate
"The serum concentration of Estrone sulfate can be decreased when it is combined with Clobazam."
Clinical Note
moderateClobazam + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Clobazam is combined with Fluticasone propionate."
Clinical Note
moderateClobazam + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Clobazam."
Clinical Note
moderateClobazam + Erythromycin
Clobazam: 36–42 hours; N-desmethylclobazam: 71–82 hours. Steady state achieved in 5–10 days.
Terminal elimination half-life is 6-8 hours in healthy adults; prolonged in renal impairment (up to 16 hours in severe impairment).
Renal: ~82% as metabolites (mainly N-desmethylclobazam and hydroxylated metabolites), unchanged clobazam <1%; fecal: ~11%.
Renal excretion of unchanged drug accounts for approximately 70% of elimination; fecal excretion accounts for approximately 30%, primarily as metabolites.
Category C
Category C
Benzodiazepine
Benzodiazepine
"The metabolism of Erythromycin can be decreased when combined with Clobazam."